Clinical trial
Tacrolimus Associated Tremors in Liver Transplant Recipients: a Randomized Open Label Trial Comparing De Novo Extended-release Once Daily (LCP-TAC) and Twice Daily Immediate-release (IR-TAC) Tacrolimus Formulations
NCT05089604 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tacrolimus Associated Tremors in Liver Transplant Recipients: a Randomized Open Label Trial Comparing De Novo Extended-release Once Daily (LCP-TAC) and Twice Daily Immediate-release (IR-TAC) Tacrolimus Formulations
- Lead sponsor
- University of British Columbia
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- January 9, 2023
- Completion date
- December 31, 2026
- Enrollment
- 124 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immunosuppression, liver transplantation, neurotoxicity, tacrolimus, tremor